SLC6A3 and Parkinson disease: These findings pave the way for longitudinal in situ PLA studies on post mortem human brains and experimental models of PD that could be pivotal to determine the relevance of the redistribution of DAT/α-synuclein complexes in the pathogenesis of this disorder.